| |
| |
|
| Insider
Information: |
Coles N Anthony |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
1,005,229 |
|
|
Indirect Shares
|
124,745 |
|
|
| Direct
Value |
$35,516,170 |
|
|
|
Indirect Value
|
$4,920,616 |
|
|
| Total
Shares |
1,129,974 |
|
|
| Total
Value |
$40,436,785 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 1.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
SVP, Comm. Ops. |
2005-02-03 |
74,540 |
2005-02-03 |
2,076 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
President, COO & Direc... |
2008-03-17 |
220,066 |
2007-01-31 |
0 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
Chairman & CEO, Director |
2013-10-01 |
0 |
2008-03-31 |
0 |
Premium* |
|
|
Laboratory Corp of America |
LH |
Director |
2013-02-15 |
2,584 |
2011-01-03 |
0 |
Premium* |
|
|
Crispr Therapeutics Ag |
CRSP |
Director |
2016-10-24 |
0 |
2016-10-24 |
70,000 |
Premium* |
|
|
McKesson Corp |
MCK |
Director |
2020-08-17 |
0 |
2018-07-25 |
0 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
1,393 |
2019-01-02 |
0 |
Premium* |
|
|
Kineta Ord Shs |
KA |
Executive Chair, Direc... |
2021-02-01 |
691,008 |
2021-02-01 |
52,669 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
|
2024-05-10 |
15,638 |
2022-12-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Comm. Ops. |
• – – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
1,920 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2007-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,000 |
52,780 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2008-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,839 |
78,619 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2008-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
76,336 |
147,638 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
282,638 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2008-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
88,891 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2009-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
75,000 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
93,064 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
– • – |
2011-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
300 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2011-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
114,796 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
– • – |
2011-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
1,000 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
– • – |
2012-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,800 |
2,800 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2012-10-16 |
4 |
AS |
$0.00 |
$0 |
D/D |
(125,599) |
108,343 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
• • – |
2013-02-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
216 |
2,584 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
26,800 |
135,254 |
0 |
- |
|
| MCK |
McKesson Corp |
Director |
– • – |
2018-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,350 |
1,350 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
323 |
323 |
0 |
- |
|
| MCK |
McKesson Corp |
Director |
– • – |
2019-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,296 |
1,296 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
320 |
643 |
0 |
- |
|
| MCK |
McKesson Corp |
Director |
– • – |
2020-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,157 |
2,453 |
0 |
- |
|
| KA |
Kineta Ord Shs |
Executive Chair |
• • – |
2020-12-22 |
4 |
A |
$0.00 |
$0 |
I/I |
52,669 |
52,669 |
0 |
- |
|
| KA |
Kineta Ord Shs |
Executive Chair |
• • – |
2020-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
689,890 |
689,890 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
902 |
0 |
- |
|
| KA |
Kineta Ord Shs |
Executive Chair |
• • – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,118 |
691,008 |
0 |
- |
|
115 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
